IRIDEX CORP

IRIX · Nasdaq · SIC 3845: Electromedical & Electrotherapeutic Apparatus
327
SEC Filings

Business Summary

IRIDEX Corporation is an ophthalmic medical technology company focused on developing and commercializing laser-based products for treating glaucoma and retinal diseases. Its proprietary MicroPulse Technology and Endpoint Management Technology enable subvisible, tissue-sparing laser therapy. Key products include the Cyclo G6 laser system, IQ 532/577 portable lasers, PASCAL system, and single-use probes (MicroPulse P3, G-Probe, EndoProbe). Fiscal year 2025 revenues were $52.7 million, with products sold in the U.S., Germany, and internationally through distributors.

Next Earnings

Q2 FY2026 — expected 2026-09-10

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionIRIXdiscussed_in_filing Healthcare & Bio
topic_mentionIRIXdiscussed_in_filing Healthcare & Bio
topic_mentionIRIXdiscussed_in_filing Healthcare & Bio
topic_mentionIRIXdiscussed_in_filing Healthcare & Bio

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-04-022026-01-030001193125-26-140194EDGAR58K words
2025-03-272024-12-280000950170-25-046107EDGAR—
2024-03-292023-12-300000950170-24-038650EDGAR—
2023-03-092022-12-310000950170-23-007061EDGAR—
2022-03-152022-01-010001564590-22-010477EDGAR—
2021-03-232021-01-020001564590-21-014859EDGAR—
2020-03-132019-12-280001564590-20-010869EDGAR—
2019-03-292018-12-290001564590-19-010196EDGAR—
2018-03-142017-12-300001564590-18-005593EDGAR—
2017-03-152016-12-310001564590-17-004462EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-122025-09-270001193125-25-277712EDGAR21K words
2025-08-122025-06-280000950170-25-107375EDGAR—
2025-05-132025-03-290000950170-25-070469EDGAR—
2024-11-122024-09-280000950170-24-125541EDGAR—
2024-08-082024-06-290000950170-24-094090EDGAR—
2024-05-142024-03-300000950170-24-059771EDGAR—
2023-11-202023-09-300000950170-23-065162EDGAR—
2023-08-102023-07-010000950170-23-041376EDGAR—
2023-05-112023-04-010000950170-23-021294EDGAR—
2022-11-102022-10-010000950170-22-024520EDGAR—
2022-08-152022-07-020000950170-22-017441EDGAR—
2022-05-122022-04-020001564590-22-019891EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-260001193125-26-126323EDGAR4K words
2026-03-130001193125-26-106190EDGAR—
2026-01-120001193125-26-009912EDGAR—
2025-12-110001193125-25-315298EDGAR—
2025-11-120001193125-25-277598EDGAR—
2025-09-090001193125-25-199190EDGAR—
2025-08-120000950170-25-107345EDGAR—
2025-06-130000950170-25-086292EDGAR—
2025-05-220000950170-25-076352EDGAR—
2025-05-200001174947-25-000809EDGAR—

327 total filings indexed. 295 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

ADMT — ADM TRONICS UNLIMITED, INC. AXGN — Axogen, Inc. BLFS — BIOLIFE SOLUTIONS INC CNMD — CONMED Corp CV — CapsoVision, Inc CBLL — Ceribell, Inc. EDAP — EDAP TMS SA ENDV — ENDONOVO THERAPEUTICS, INC.

Tags

glaucoma-treatment medical-retina surgical-retina ophthalmology united-states germany international-markets continuous-wave-(cw)-laser-photocoagulation micropulse-technology endpoint-management-technology pattern-scanning-laser-(pascal) transscleral-laser-therapy-(tlt) micropulse-laser-trabeculoplasty-(mlt) pattern-scanning-laser-trabeculoplasty-(pslt)

Company Identity

CIK0001006045
TickerIRIX
ExchangeNasdaq
SIC3845: Electromedical & Electrotherapeutic Apparatus
IncorporatedDE
HeadquartersMountain View, California

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 3b71c075a9fcd0a220a79a4d52a4111294673cc146cbb6812693c60062480076
parent: ab8d4945059c044fc9663fb7bbb0bd69fa70fd35b8a8f25b36b8ce3afdf74536
content hash: 21509f456b5ca5e11017edbc4bd78a4f0f58dda8828563006b09e80424886ab7
signed: 2026-04-13T04:45:45.004Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf